Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
02 2019
Historique:
received: 01 08 2018
accepted: 07 09 2018
pubmed: 15 9 2018
medline: 6 5 2020
entrez: 15 9 2018
Statut: ppublish

Résumé

T-cell/histiocyte-rich large B-cell lymphoma is a rare aggressive lymphoma showing histopathological overlap with nodular lymphocyte-predominant Hodgkin lymphoma. Despite differences in tumor microenvironment and clinical behavior, the tumor cells of both entities show remarkable similarities, suggesting that both lymphomas might represent a spectrum of the same disease. To address this issue, we investigated whether these entities share mutations. Ultra-deep targeted resequencing of six typical and 11 histopathological variants of nodular lymphocyte-predominant Hodgkin lymphoma, and nine cases of T-cell/histiocyte-rich large B-cell lymphoma revealed that genes recurrently mutated in nodular lymphocyte-predominant Hodgkin lymphoma are affected by mutations at similar frequencies in T-cell/histiocyte-rich large B-cell lymphoma. The most recurrently mutated genes were

Identifiants

pubmed: 30213827
pii: haematol.2018.203224
doi: 10.3324/haematol.2018.203224
pmc: PMC6355500
doi:

Substances chimiques

Biomarkers, Tumor 0
Immediate-Early Proteins 0
JunB protein, human 0
SOCS1 protein, human 0
Suppressor of Cytokine Signaling 1 Protein 0
Transcription Factors 0
CREB-Binding Protein EC 2.3.1.48
CREBBP protein, human EC 2.3.1.48
Protein Serine-Threonine Kinases EC 2.7.11.1
serum-glucocorticoid regulated kinase EC 2.7.11.1
DUSP2 protein, human EC 3.1.3.48
Dual Specificity Phosphatase 2 EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-337

Informations de copyright

Copyright © 2019 Ferrata Storti Foundation.

Références

Blood. 1999 Apr 15;93(8):2679-87
pubmed: 10194448
Blood. 2006 Aug 1;108(3):1013-20
pubmed: 16614247
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18667-72
pubmed: 25512519
Nature. 2011 Jul 27;476(7360):298-303
pubmed: 21796119
PLoS One. 2013 Nov 11;8(11):e78812
pubmed: 24244368
Haematologica. 2010 Mar;95(3):440-8
pubmed: 19797726
Cell Rep. 2015 Nov 17;13(7):1418-1431
pubmed: 26549456
Nature. 1994 Jul 21;370(6486):223-6
pubmed: 7913207
J Pathol. 2005 Apr;205(5):541-7
pubmed: 15732141
Immunol Rev. 1998 Apr;162:153-60
pubmed: 9602361
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9337-42
pubmed: 9256483
Blood. 2015 Jul 23;126(4):508-19
pubmed: 26082451
Clin Cancer Res. 2016 May 1;22(9):2290-300
pubmed: 26647218
Blood. 2007 Nov 1;110(9):3387-90
pubmed: 17652621
Nature. 2001 Jul 19;412(6844):341-6
pubmed: 11460166
Nat Genet. 2014 Apr;46(4):329-35
pubmed: 24531327
Blood. 2018 May 31;131(22):2454-2465
pubmed: 29650799
Oncotarget. 2012 Nov;3(11):1308-19
pubmed: 23131835
Genes Chromosomes Cancer. 2016 Mar;55(3):251-67
pubmed: 26608593
Nature. 2011 Mar 10;471(7337):189-95
pubmed: 21390126
Blood. 2009 Nov 12;114(20):4503-6
pubmed: 19734449
Blood. 2013 Dec 19;122(26):4246-52; quiz 4292
pubmed: 24100447
Cell. 2014 Dec 18;159(7):1524-37
pubmed: 25483777
Br J Haematol. 2015 May;169(3):415-22
pubmed: 25644177
Cell Rep. 2014 Jan 16;6(1):130-40
pubmed: 24388756
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403
pubmed: 23292937
J Exp Med. 2008 Sep 29;205(10):2251-68
pubmed: 18794340
Oncotarget. 2013 Jan;4(1):35-47
pubmed: 23296022
Am J Surg Pathol. 2003 Oct;27(10):1346-56
pubmed: 14508396
Blood. 2016 Feb 25;127(8):1007-16
pubmed: 26675346
Leukemia. 2016 Apr;30(4):844-53
pubmed: 26658840
Histopathology. 2002 Jan;40(1):31-45
pubmed: 11903596

Auteurs

Bianca Schuhmacher (B)

Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.

Julia Bein (J)

Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.

Tobias Rausch (T)

Genecore, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.

Vladimir Benes (V)

Genecore, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.

Thomas Tousseyn (T)

Department of Pathology, University Hospitals K.U. Leuven, Belgium.

Martine Vornanen (M)

Department of Pathology, Tampere University Hospital and University of Tampere, Finland.

Maurilio Ponzoni (M)

Unit of Lymphoid Malignancies, Department of Pathology, Scientific Institute San Raffaele, Milan, Italy.

Lorenz Thurner (L)

José Carreras Center for Immuno and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg, Saar, Germany.
Department of Internal Medicine 2, Hospital of the J. W. Goethe University, Frankfurt am Main, Germany.

Randy Gascoyne (R)

Department of Pathology and Laboratory Medicine and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada.

Christian Steidl (C)

Department of Pathology and Laboratory Medicine and the Centre for Lymphoid Cancer, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada.

Ralf Küppers (R)

Institute of Cell Biology (Cancer Research), Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Deutsches Konsortium für Translationale Krebsforschung (DKTK), Germany.

Martin-Leo Hansmann (ML)

Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany.
Reference and Consultant Center for Lymphoma and Lymph Node Diagnostics, Goethe University, Frankfurt am Main, Germany.
Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.

Sylvia Hartmann (S)

Dr. Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany s.hartmann@em.uni-frankfurt.de.
Reference and Consultant Center for Lymphoma and Lymph Node Diagnostics, Goethe University, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH